<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vernon KA</submitter><funding>Wellcome Trust</funding><pagination>1334-42</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4849824</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(5)</volume><pubmed_abstract>The complement-mediated renal diseases C3 glomerulopathy (C3G) and atypical hemolytic uremic syndrome (aHUS) strongly associate with inherited and acquired abnormalities in the regulation of the complement alternative pathway (AP). The major negative regulator of the AP is the plasma protein complement factor H (FH). Abnormalities in FH result in uncontrolled activation of C3 through the AP and associate with susceptibility to both C3G and aHUS. Although previously developed FH-deficient animal models have provided important insights into the mechanisms underlying susceptibility to these unique phenotypes, these models do not entirely reproduce the clinical observations. FH is predominantly synthesized in the liver. We generated mice with hepatocyte-specific FH deficiency and showed that t</pubmed_abstract><journal>Journal of the American Society of Nephrology : JASN</journal><pubmed_title>Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.</pubmed_title><pmcid>PMC4849824</pmcid><funding_grant_id>098476</funding_grant_id><funding_grant_id>098476/Z/12/Z</funding_grant_id><funding_grant_id>WT082291MA</funding_grant_id><pubmed_authors>Botto M</pubmed_authors><pubmed_authors>Malik TH</pubmed_authors><pubmed_authors>Vernon KA</pubmed_authors><pubmed_authors>Ruseva MM</pubmed_authors><pubmed_authors>Pickering MC</pubmed_authors><pubmed_authors>Cook HT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.</name><description>The complement-mediated renal diseases C3 glomerulopathy (C3G) and atypical hemolytic uremic syndrome (aHUS) strongly associate with inherited and acquired abnormalities in the regulation of the complement alternative pathway (AP). The major negative regulator of the AP is the plasma protein complement factor H (FH). Abnormalities in FH result in uncontrolled activation of C3 through the AP and associate with susceptibility to both C3G and aHUS. Although previously developed FH-deficient animal models have provided important insights into the mechanisms underlying susceptibility to these unique phenotypes, these models do not entirely reproduce the clinical observations. FH is predominantly synthesized in the liver. We generated mice with hepatocyte-specific FH deficiency and showed that t</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 May</publication><modification>2025-04-04T07:30:37.014Z</modification><creation>2019-03-27T02:12:40Z</creation></dates><accession>S-EPMC4849824</accession><cross_references><pubmed>26374608</pubmed><doi>10.1681/ASN.2015030295</doi><doi>10.1681/asn.2015030295</doi></cross_references></HashMap>